Shin Ebara

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Satoru Shimura, Guang Yang, Shin Ebara et al. · PubMed · 2000 · 274 citations

Medicine, Oncology, Pathology +17

Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

Salahaldin A. Tahir, Guang Yang, Shin Ebara et al. · PubMed · 2001 · 217 citations

Medicine, Endocrinology, Oncology +12

Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.

Likun Li, Guang Yang, Shin Ebara et al. · PubMed · 2001 · 191 citations

Medicine, Molecular Biology, Oncology +16

Adenovirus-Mediated Overexpression of REIC/Dkk-3 Selectively Induces Apoptosis in Human Prostate Cancer Cells through Activation of c-Jun-NH2-Kinase

Fernando Abarzúa, Masakiyo Sakaguchi, Mikiro Takaishi et al. · Cancer Research · 2005 · 186 citations · Full text

Life Sciences, Cell Biology, Oncology +17